oxidopamine and Cancer of Liver

oxidopamine has been researched along with Cancer of Liver in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
An, W; Bai, XX; Bao, LH; Gu, L; Wang, XM; Xi, SS; Yang, HM; Zhang, H	1

Other Studies

1 other study(ies) available for oxidopamine and Cancer of Liver

Article	Year
Metabotropic glutamate receptor 5 mediates the suppressive effect of 6-OHDA-induced model of Parkinson's disease on liver cancer. Pharmacological research, 2017, Volume: 121 Topics: Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Models, Animal; Glutamic Acid; Liver; Liver Neoplasms; Male; MAP Kinase Signaling System; Mice; Oxidopamine; Parkinson Disease, Secondary; Proto-Oncogene Proteins c-akt; Rats, Sprague-Dawley; Receptor, Metabotropic Glutamate 5	2017

Article

Year

Metabotropic glutamate receptor 5 mediates the suppressive effect of 6-OHDA-induced model of Parkinson's disease on liver cancer.

Pharmacological research, 2017, Volume: 121

Topics: Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Models, Animal; Glutamic Acid; Liver; Liver Neoplasms; Male; MAP Kinase Signaling System; Mice; Oxidopamine; Parkinson Disease, Secondary; Proto-Oncogene Proteins c-akt; Rats, Sprague-Dawley; Receptor, Metabotropic Glutamate 5

2017